Revolutionise Your Oligonucleotide Pipeline to Redefine Therapeutics for CNS Disorders
Expanding on the success of the 5th Oligonucleotide for CNS US Sumit, we are delighted to announce the Inaugural Oligonucleotide for CNS Europe Summit.
Over three days in Amsterdam, 60+ senior leading executives and thought leaders across neurobiology, oligonucleotide chemistry, DMPK and in vivo sciences, translational medicine, and CNS delivery strategies to explore the latest innovations in oligonucleotide chemistry, conjugation strategies, delivery technologies, and translational models designed to tackle previously undruggable neurological targets.
This multidisciplinary forum combines data-driven presentations, interactive roundtables, and networking sessions, providing actionable insights into crossing the blood–brain barrier, optimizing PK/PD, advancing backbone and conjugate design, and translating preclinical findings into clinical success.
Capitalizing on Europe’s growing biotech momentum, this summit offers a unique opportunity to connect with peers, discover emerging trends, and position your organization at the forefront of the blooming CNS oligonucleotide space- April in Amsterdam will be Tulip season after all…
What to Expect?
Optimise Oligo Conjugates
Learn strategies for linker–cargo design to maximise therapeutic index while ensuring manufacturability and clinical-grade safety.
Next-Generation CNS Delivery
Explore advanced BBB shuttle technologies and organoid models to enhance CNS penetration.
Translational Insights
Integrate in vitro, PK/PD, and in vivo data to bridge preclinical findings to clinical dosing and efficacy.
Modality & Backbone Innovation
Navigate emerging oligo platforms, safety comparisons, and backbone modifications for safer, more targeted CNS delivery.
Unmissable Event Highlights
Breakfast Briefing
Whether you’re experienced in CNS but new to oligonucleotides, a seasoned oligo scientist exploring CNS, or transitioning from small molecules, bring your team and start the conference on the same page. Gain expert insights and ask your burning questions in an interactive session designed to level-set all attendees.
Networking Opportunities
Connect 1:1 with leading experts, exchange perspectives on the industry’s biggest challenges, and build meaningful relationships through roundtables, open discussions, and dedicated networking hours.
Data-Driven Insights
Hear the latest breakthroughs in CNS-targeted oligonucleotides, including delivery strategies, backbone modifications, translational models, and clinical learnings, all designed to accelerate your research and pipeline.
Explore the Full Event Guide
- Get a full overview of the agenda, speakers, and session topics in one place
- Share easily with your team to assess and mobilize interest
- Preview 7+ sessions containing brand-new data that we’ll be showcasing at the event
- Discover exclusive content from keynotes, academics, C-suite leaders, biotechs and biopharma executives
- Explore attendee benefits, exclusive event insights and anticipated audience metrics
Attending Companies Include
Explore the Agenda
Gain targeted insight into CNS oligonucleotide development, from BBB delivery and conjugation chemistry to translational modelling and clinical learning.
Partner With Us
Position your organisation at the centre of Europe’s CNS oligonucleotide ecosystem as it rapidly scales.
Join Biopharma Experts
Connect with senior CNS, RNA, and oligo leaders shaping the future of RNA-targeted neurological therapies.